Patent ID: 11858884
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The method according to claim 1, wherein the core of the compound of Formula (I), or the pharmaceutically acceptable salt thereof, corresponds to the structure of Formula (III):, wherein, in Formula (III):
X2 is N(R5)y, wherein:
R5 is hydrogen or optionally substituted alkyl(C≤8); and
y is 0 or 1 provided that the sum of y and z is 3;
R2 is amino, optionally substituted alkylamino(C≤12), or optionally substituted dialkylamino(C≤12);
b is 1, 2, 3, 4, 5, or 6; and
z is 2 or 3; provided that the sum of z and y is 3.